Source Capital is an insurance private equity investment management institution.
Source Capital is an insurance private equity investment management institution.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 23, 2022
Guangzhou Baiyunshan Pharmaceutical Holdings
|
Post-IPO Equity | $1.43M | Manufacturing | Yes |
|
Feb 25, 2021
Moody
|
Series B | $39.25M | Beauty | — |
|
Jan 28, 2021
Moody
|
Series B | $19.64M | Beauty | — |
|
Jul 21, 2018
Yingsheng Biology
|
Series A | — | Biotechnology | — |
|
Nov 12, 2017
Frasergen
|
Series B | ¥50M | Bioinformatics | — |
Source Capital has had 2 exits. Source Capital most notable exits include Geneis , Guangzhou Baiyunshan Pharmaceutical Holdings
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 2, 2018 | Geneis | IPO | Health Care | Detail |
| Feb 6, 2001 | Guangzhou Baiyunshan Pharmaceutical Holdings | IPO | Manufacturing | Detail |